Patent · US Active

Composition for use in the treatment of epilepsy

US11351138B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 9, 2018
Grant dateJun 7, 2022
Priority date
Expiry dateSep 10, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition comprising a decanoic acid to octanoic acid ratio of 70:30 to 90:10 wt/wt for use in treating epilepsy or controlling epileptic seizures.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.